Juan I. Young

Juan I. Young

Auto-generated profile, based on publicly available information

Juan I. Young

Centro de Estudios Científicos, Valdivia 5110246 , Chile

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
BKBredford Kerr
Bredford Kerr
MAMatías Alvarez-Saavedra
Matías Alvarez-Saavedra
MVMauricio Alejandro Sáez Venegas
Mauricio Alejandro Sáez Venegas
ASAlexandra Saona
Alexandra Saona
JYJuan I. Young
Juan I. Young
MeCP2 is an abundant protein that binds to methylated cytosine residues in DNA and regulates transcription. Mutations in MECP2 cause Rett syndrome, a severe neurological disorder that affects approximately 1:10 000 females. Mice lacking MeCP2 have been generated and constitute important models of Rett syndrome. However, it is yet unclear whether certain physiological events are sensitive to a decrease, rather than a complete lack of MeCP2. Here we report that a Mecp2 floxed allele (Mecp2lox) that was generated to allow conditional mutagenesis behaves as a hypomorph and the corresponding mutant mice exhibit phenotypical alterations including body weight gain, motor abnormalities and altered social behavior. Our data reinforce the view that the central nervous system is extremely sensitive to MeCP2 expression levels and suggest that the 3′-UTR of Mecp2 might contain important elements that contribute to the regulation of its stability or processing.

17 July 2007 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MAMatías Alvarez-Saavedra
Matías Alvarez-Saavedra
MVMauricio Alejandro Sáez Venegas
Mauricio Alejandro Sáez Venegas
DKDongcheul Kang
Dongcheul Kang
HZHuda Y. Zoghbi
Huda Y. Zoghbi
JYJuan I. Young
Juan I. Young
Rett syndrome (RTT), a leading cause of mental retardation with autistic features in females, is caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). RTT is characterized by a diverse set of neurological features that includes cognitive, motor, behavioral and autonomic disturbances. The diverse features suggest that specific neurons contribute to particular phenotypes and raise the question whether restoring MeCP2 function in a cell-specific manner will rescue some of the phenotypes seen in RTT. To address this, we generated transgenic mice expressing inducible MeCP2 under the control of the brain-specific promoters calcium/calmodulin-dependent protein kinase II (CamKII) or neuron-specific enolase (Eno2) and bred them onto mouse models lacking functional MeCP2. Expression of normal MeCP2 in either CamKII or Eno2 distribution was unable to prevent the appearance of most of the phenotypes of the RTT mouse models. These results suggest that most RTT phenotypes are caused either by disruption of complex neural networks involving neurons throughout the brain or by disruption of the function of specific neurons outside of the broad CamKII or Eno2 distribution.